| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Aug 11, 2026 | Sell(S) | 4K | $46.90 | $172K | 511K |
| Aug 11, 2026 | Sell(S) | 20K | $48.04 | $937K | 492K |
| Aug 11, 2026 | Sell(S) | 6K | $48.62 | $282K | 486K |
| Aug 10, 2026 | Sell(S) | 14K | $45.97 | $651K | 523K |
| Aug 10, 2026 | Sell(S) | 8K | $46.75 | $391K | 515K |
Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-346995) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for Rapport Therapeutics, Inc.
This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/filing/0001193125-26-346995"
Use Arkolith to summarize insider buying and selling at Rapport Therapeutics, Inc. over the last 90 days and cite the filings.